Sitagliptin attenuates cardiomyopathy by modulating the JAK/STAT signaling pathway in experimental diabetic rats. - Al-Rasheed NM; Hasan IH; Al-Amin MA; Al-Ajmi HN; Mahmoud AM (Drug design, development and therapy, 2016)